MBX
MBX Biosciences, Inc.
53.60$
-3.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | +31.3% | +58.7% | – | – | +29.9% | +0.0% | -40.0% | +6.7% | – | – | |
| – | – | – | – | – | – | -169.4% | – | – | – | – | – | – | |
| – | -14.8% | +43.0% | +30.3% | +16.3% | -9.1% | +47.2% | -20.9% | +8.7% | +2.5% | -6.5% | +67.7% | – | |
| – | +20.9% | +0.0% | -0.1% | +26.7% | +18.2% | +21.8% | -1.0% | +14.1% | +29.6% | +45.7% | +13.1% | – | |
| – | -8.7% | +33.3% | +25.1% | +17.7% | -5.1% | +42.6% | -17.8% | +9.7% | +7.8% | +5.7% | +50.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.